The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, open-label, single-arm phase II clinical study of inetetamab in combination with pyrotinib and albumin-bound paclitaxel for the neoadjuvant treatment of patients with HER2+ early and locally advanced breast cancer.
 
Jiang Wu
No Relationships to Disclose
 
Fengqiang Cui
No Relationships to Disclose
 
Yuqing Yang
No Relationships to Disclose
 
Jing Yu
No Relationships to Disclose
 
Jixin Yang
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Dongdong Xu
No Relationships to Disclose
 
Wenyu Hu
No Relationships to Disclose
 
Jialing Luo
No Relationships to Disclose
 
Wen Ma
No Relationships to Disclose
 
Nanlin Li
No Relationships to Disclose